G'day Searcher2. They spent over $3 million on exploration for y/e 30 June 2017, $2.7 m of which went into the Harrier survey in APT594. They'll get a mention in their tax return.
"In its capacity as Operator, Icon assumed the rehabilitation liability for the exploration program (in APT855) estimated at $5.23 million and all joint venture assets, including inventory and chemicals to the value of $4.89 million."
One would hope that they will be able to use those assets and chemicals in APT855 before they need to comply with that rehabilitation liability.
They usually pick up a very nice cheque for R&D, but, not much detail on what R&D they have done since the last cheque.
Very quiet on market, so, no "signals" from what has become our only source of VERY (indirect) information. That's what I'm watching without direct announcements from the company.
As an aside, note Robert Gotliebsen's article in The Australian how there is just 1 growth company, CSL, in the top 20 ASX listed companies. What does THAT tell us about Australian investment in our own economy and I BET that most of their executives are on very handsome salaries and SHORT TERM bonuses!!!
ICN Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held
(20min delay)